SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Seal Rock Therapeutics to Present SRT-015 Data at Liver Meeting

The company says preclinical studies showed 100% survival and sustained bile flow in an experimental model of bi

Related stories